Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia - PubMed (original) (raw)
Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia
S H Kim et al. J Cell Biol. 1993 Nov.
Abstract
SV-40 T antigen (TAg), human K-rasVal12, and a dominant negative mutant of human p53 (p53Ala143) have been expressed singly and in all possible combinations in postmitotic enterocytes distributed throughout the duodenal-colonic axis of 1-12-mo-old FVB/N transgenic mice to assess the susceptibility of this lineage to gene products implicated in the pathogenesis of human gut neoplasia. SV-40 TAg produces re-entry into the cell cycle. Transgenic pedigrees that produce K-rasVal12 alone, p53Ala143 alone, or K-rasVal12 and p53Ala143 have no detectable phenotypic abnormalities. However, K-rasVal12 cooperates with SV-40 TAg to generate marked proliferative and dysplastic changes in the intestinal epithelium. These abnormalities do not progress to form adenomas or adenocarcinomas over a 9-12-mo period despite sustained expression of the transgenes. Addition of p53Ala143 to enterocytes that synthesize SV-40 TAg and K-rasVal12 does not produce any further changes in proliferation or differentiation. Mice that carry one, two, or three of these transgenes were crossed to animals that carry Min, a fully penetrant, dominant mutation of the Apc gene associated with the development of multiple small intestinal and colonic adenomas. A modest (2-5-fold) increase in tumor number was noted in animals which express SV-40 TAg alone, SV-40 TAg and K-rasVal12, or SV-40 TAg, K-rasVal12 and p53Ala143. However, the histopathologic features of the adenomas were not altered and the gut epithelium located between tumors appeared similar to the epithelium of their single transgenic, bi-transgenic, or tri-transgenic parents without Min. These results suggest that (a) the failure of the dysplastic gut epithelium of SV-40 TAg X K-rasVal12 mice to undergo further progression to adenomas or adenocarcinomas is due to the remarkable protective effect of a continuously and rapidly renewing epithelium, (b) initiation of tumorigenesis in Min mice typically occurs in crypts rather than in villus-associated epithelial cell populations, and (c) transgenic mouse models of neoplasia involving members of the enterocytic lineage may require that gene products implicated in tumorigenesis be directed to crypt stem cells or their immediate descendants. Nonetheless, directing K-rasVal12 production to proliferating and nonproliferating cells in the lower and upper half of small intestinal and colonic crypts does not result in any detectable abnormalities.
Similar articles
- Bi-transgenic mice reveal that K-rasVal12 augments a p53-independent apoptosis when small intestinal villus enterocytes reenter the cell cycle.
Coopersmith CM, Chandrasekaran C, McNevin MS, Gordon JI. Coopersmith CM, et al. J Cell Biol. 1997 Jul 14;138(1):167-79. doi: 10.1083/jcb.138.1.167. J Cell Biol. 1997. PMID: 9214390 Free PMC article. - Expression of SV-40 T antigen in the small intestinal epithelium of transgenic mice results in proliferative changes in the crypt and reentry of villus-associated enterocytes into the cell cycle but has no apparent effect on cellular differentiation programs and does not cause neoplastic transformation.
Hauft SM, Kim SH, Schmidt GH, Pease S, Rees S, Harris S, Roth KA, Hansbrough JR, Cohn SM, Ahnen DJ, et al. Hauft SM, et al. J Cell Biol. 1992 May;117(4):825-39. doi: 10.1083/jcb.117.4.825. J Cell Biol. 1992. PMID: 1349609 Free PMC article. - Cell lineage-specific and differentiation-dependent patterns of CCAAT/enhancer binding protein alpha expression in the gut epithelium of normal and transgenic mice.
Chandrasekaran C, Gordon JI. Chandrasekaran C, et al. Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8871-5. doi: 10.1073/pnas.90.19.8871. Proc Natl Acad Sci U S A. 1993. PMID: 8415623 Free PMC article. - WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis.
Li M, Lewis B, Capuco AV, Laucirica R, Furth PA. Li M, et al. Oncogene. 2000 Feb 21;19(8):1010-9. doi: 10.1038/sj.onc.1203271. Oncogene. 2000. PMID: 10713684 Review.
Cited by
- KLF5 mediates the hyper-proliferative phenotype of the intestinal epithelium in mice with intestine-specific endogenous K-RasG12D expression.
Nandan MO, Bialkowska AB, Yang VW. Nandan MO, et al. Am J Cancer Res. 2018 Apr 1;8(4):723-731. eCollection 2018. Am J Cancer Res. 2018. PMID: 29736317 Free PMC article. - Viral oncogene expression in the stem/progenitor cell compartment of the mouse intestine induces adenomatous polyps.
Sáenz Robles MT, Chong JL, Koivisto C, Trimboli A, Liu H, Leone G, Pipas JM. Sáenz Robles MT, et al. Mol Cancer Res. 2014 Oct;12(10):1355-64. doi: 10.1158/1541-7786.MCR-14-0166. Epub 2014 Jul 3. Mol Cancer Res. 2014. PMID: 24994749 Free PMC article. - Estrogenic modulation of uropathogenic Escherichia coli infection pathogenesis in a murine menopause model.
Wang C, Symington JW, Ma E, Cao B, Mysorekar IU. Wang C, et al. Infect Immun. 2013 Mar;81(3):733-9. doi: 10.1128/IAI.01234-12. Epub 2012 Dec 21. Infect Immun. 2013. PMID: 23264047 Free PMC article. - Foxn1 regulates lineage progression in cortical and medullary thymic epithelial cells but is dispensable for medullary sublineage divergence.
Nowell CS, Bredenkamp N, Tetélin S, Jin X, Tischner C, Vaidya H, Sheridan JM, Stenhouse FH, Heussen R, Smith AJ, Blackburn CC. Nowell CS, et al. PLoS Genet. 2011 Nov;7(11):e1002348. doi: 10.1371/journal.pgen.1002348. Epub 2011 Nov 3. PLoS Genet. 2011. PMID: 22072979 Free PMC article. - Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool.
Feng Y, Bommer GT, Zhao J, Green M, Sands E, Zhai Y, Brown K, Burberry A, Cho KR, Fearon ER. Feng Y, et al. Gastroenterology. 2011 Sep;141(3):1003-1013.e1-10. doi: 10.1053/j.gastro.2011.05.007. Epub 2011 May 18. Gastroenterology. 2011. PMID: 21699772 Free PMC article.
References
- Oncogene. 1989 Jun;4(6):715-24 - PubMed
- Mol Cell Biol. 1989 Sep;9(9):3982-91 - PubMed
- J Virol. 1989 Dec;63(12):5459-63 - PubMed
- J Cell Biol. 1989 Dec;109(6 Pt 2):3231-42 - PubMed
- Science. 1990 Jan 5;247(4938):49-56 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous